Top Markets
#1 Status Status +20.04%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.47%
#3 Ontology Gas Ontology Gas +12.46%
#4 GoPlus Security GoPlus Security +12.16%
#5 DMT-NAT DMT-NAT +9.70%
#6 Fake World Assets Fake World Assets +8.34%
#7 Provenance Blockchain Provenance Blockchain +6.75%
#8 Bedrock Bedrock +6.48%
#9 Janction Janction +6.24%
#10 Ontology Ontology +5.54%
Coin of the day
Status Status
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Curanex Pharmaceuticals Inc Common Stock Curanex Pharmaceuticals Inc Common Stock

Curanex Pharmaceuticals Inc Common Stock

CURX
Pozycja w akcjach #34062
Curanex Pharmaceuticals Inc. is an emerging biopharmaceutical company focused... Curanex Pharmaceuticals Inc. is an emerging biopharmaceutical company focused on identifying, advancing, and bringing to market plant-based medicines to address various inflammatory conditions. Their primary drug candidate, Phyto-N, is currently in development for a broad spectrum of health issues, including but not limited to ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, gout, and acne. Established in 1996 and based in Jericho, New York, the company was formerly known as Fordman Pharma Inc. before adopting its current name in November 2023.
Cena akcji
$0.223
Ostatnia synchronizacja: 2026-08-14
Kapitalizacja rynkowa
$6.32M
Zmiana (1 dzień)
1.64%
Zmiana (1 rok)
-
Kraj
US
Handel Curanex Pharmaceuticals Inc Common Stock (CURX)

Kategoria

Healthcare
EPS dla Curanex Pharmaceuticals Inc Common Stock (CURX)
EPS na dzień 2026 TTM: 0
Według najnowszych raportów finansowych i ceny akcji firmy Curanex Pharmaceuticals Inc Common Stock, obecny EPS (TTM) wynosi 0. Na koniec roku 2026 firma miała EPS w wysokości 0, równa się do EPS z roku 2026, który wynosił 0.
Historia EPS dla Curanex Pharmaceuticals Inc Common Stock od 2026 do 2026
EPS na koniec każdego roku
Rok EPS Zmień
Za mało danych dla podanych dat.
EPS dla podobnych firm lub konkurentów
Firma EPS Różnica w EPS Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $13.70 -
BE